Others Want Diagnostic Data, Labs Should Too

By R. Lewis Dark | From the Volume XXXII, No. 8 – June 2, 2025 Issue

ONE NEED NOT LOOK FURTHER THAN THE PAGES OF THIS ISSUE OF THE DARK REPORT to once again realize the importance of the diagnostic data residing within your clinical laboratory operations. Perhaps it’s rote to say “diagnostic data is a gold mine” for labs…

Read More

---

Leveraging Data to Create Lab and Healthcare Efficiencies

By Robert Michel | From the Volume XXXII, No. 8 – June 2, 2025 Issue

CEO SUMMARY: In this exclusive interview with The Dark Report, Bradley Bostic, founder, chair, and CEO of healthcare and laboratory data intelligence company hc1 discusses trends in healthcare, how to position clinical laboratories as a strategic asset, and ways to analyze…

Read More

---

Elizabeth Holmes’ Partner Sought Campaign to Get Her Out of Jail

By Scott Wallask | From the Volume XXXII, No. 8 – June 2, 2025 Issue

IN A BRIEF MENTION THAT WENT LARGELY UNNOTICED,  a well-known marketing professor said he declined a request by Billy Evans—the partner of disgraced Theranos founder Elizabeth Holmes—to help organize an effort to get Holmes out of prison. “[Evans] reached out t…

Read More

---

Economic, Tech Changes Drive Lab Concerns

By Robert Michel | From the Volume XXXII, No. 7 – May 12, 2025 Issue

CEO SUMMARY: Uncertainty around tariffs, future regulations, and artificial intelligence (AI) defined the mood at the 2025 Executive War College, where nearly 1,000 lab leaders gathered. Speakers warned of how stagnant healthcare spending could trickle down to labs. Meanwh…

Read More

---

May 12, 2025, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXII, No. 7 – May 12, 2025 Issue

Yet another clinical laboratory has sold off part of its services to a national commercial lab. Labcorp announced on April 21 that it had finalized its acquisition of North Mississippi Health Services’ (NMHS) ambulatory outreach laboratory business. A…

Read More

---

With LDT Rule Vacated, Labs Await FDA Retort

By Robert Michel | From the Volume XXXII, No. 6 – April 21, 2025 Issue

CEO SUMMARY: In a major win for clinical laboratories, a federal judge vacated the FDA’s final rule on LDTs, writing in his decision that the agency overstepped its authority. For now, labs can develop and modify LDTs without FDA oversight, but future action in some form…

Read More

---

Medical Robotics Developer Says It’s Time to Transform Phlebotomy

By Robert Michel | From the Volume XXXII, No. 4 – March 10, 2025 Issue

“Our innovation aims to make blood draws fully autonomous, safer, faster, more accurate, less painful, and more accessible.” —Brian Joseph, co-founder, Vitestro CEO SUMMARY: Phlebotomy and collection of veinous blood is one important procedure in clinical…

Read More

---

Upcoming Executive War College to Cover Important Lab Trends

By Robert Michel | From the Volume XXXII, No. 4 – March 10, 2025 Issue

New developments now changing the landscape in health-care and the clinical laboratory market will be addressed at the upcoming 30th Annual Executive War College on Diagnostic, Clinical Laboratory, and Pathology Management that happens on April 29-30, 20…

Read More

---

Quest Diagnostics, Labcorp Issue Q4 and Full Year 2024 Earnings

By Robert Michel | From the Volume XXXII, No. 3 – February 17, 2025 Issue

LAB ACQUISITIONS IN 2024 WERE A CONTRIBUTING FACTOR TO REVENUE GROWTH at the nation’s two biggest clinical laboratory companies. This was reflected in the fourth quarter and full year 2024 earnings reports issued by Labcorp and Quest Diagnostics. Here are recently …

Read More

---

Grim Realities Drive Payer Behavior with Lab Test Claims

By Robert Michel | From the Volume XXXII, No. 3 – February 17, 2025 Issue

…

Read More

---